W.D.J.K Amarasena

Dr. W.D.J.K Amarasena

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2023 in Journal of the College of Community Physicians of Sri Lanka
Verified
Journal Article
Open access
PDF file
UKUpeksha Gayani Karawita
Upeksha Gayani Karawita
SWSarasi Withana
Sarasi Withana
STShanaz Thasleem
Shanaz Thasleem
WAW.D.J.K Amarasena
W.D.J.K Amarasena
BMBuddhika Mahesh
Buddhika Mahesh
WGWasantha Gunathunga
Wasantha Gunathunga
Introduction: Diabetes mellitus which is characterized by chronic hyperglycaemia accounts for 1.6 million deaths per year globally. In Sri Lanka, 7.4% of adults are with raised fasting blood glucose. Phyllanthus emblica, some fruit, which is also called by Nelli, Amla or Indian Gooseberry, is traditionally believed to facilitate control of hyperglycaemia.Objectives: To systematically review the glycaemic control effect of Phyllanthus emblica.Methods: PubMed, EMBASE, Cochrane Library, CINAHL and AGRICOLA databases were searched to select relevant studies. Studies were selected in two rounds. Three screening questions consisted of; whether study was a human study with Phyllanthus emblica included as a fruit or an ingredient, outcomes were related to glycaemic control and outcomes being reported quantitatively. Following the review of titles and abstracts, full articles were reviewed with screening questions such as, study design, participants, intervention, and findings of outcome. Two reviewers independently screened articles with the third intervening in resolving the conflicts. Meta-analysis was not performed following the heterogeneity assessments and narrative review of the findings was done.Results: Eighteen studies were selected, having respectively excluding 81, 106 and 22 studies with reference to three screening questions. Six studies were done among healthy individuals and 12 were done among patients with diabetes. The studies were conducted among the age group of 18-75 years. Sample sizes of studies ranged from 10 to 150 participants, with 951 participants in total. In three studies, Phyllanthus emblica was used as a single entity and in 15, it was one component of a combined product. Fifteen selected studies described the mean fasting blood sugar (FBS) levels and 13 of them showed statistically what Phyllanthus emblica or products containing it had on glycaemic control, compared to control group (p<0.001). Out of those 13 studies with significant findings on glycaemic control, 10 studies were done among hyperglycaemic patients. In eight studies, a significant reduction in HbA1c results (p <0.05) was observed and nine studies showed a significant reduction in post prandial blood sugar (PPBS) levels (p<0.05). None of the selected studies showed any negative impact of Phyllanthus emblica on blood glucose levels among either healthy or diabetics individuals.Conclusions & Recommendations: Phyllanthus emblica is found to be with favourable effects in facilitating blood sugar control. Further research on the potential application of it as a glycaemic controller, must be encouraged.

14 November 2020 in Journal of the College of Community Physicians of Sri Lanka
Verified
Journal Article
Open access
PDF file
IMIrshad Mashood
Irshad Mashood
RRR. M. T. D. Rathnayake
R. M. T. D. Rathnayake
GDG. S. Dissanayake
G. S. Dissanayake
WAW.D.J.K Amarasena
W.D.J.K Amarasena
Prasad Chathuranga WeerasinghePrasad Chathuranga Weerasinghe
Prasad Chathuranga Weerasinghe
ALAthula Liyanapathirana
Athula Liyanapathirana

14 November 2020 in Journal of the College of Community Physicians of Sri Lanka
Verified
Journal Article
Open access
PDF file
Prasad Chathuranga WeerasinghePrasad Chathuranga Weerasinghe
Prasad Chathuranga Weerasinghe
IGIndumini Gunatilake
Indumini Gunatilake
NANirma Alpitiarachchi
Nirma Alpitiarachchi
BGBalangoda Muhamdiramlage Indika Gunawardana
Balangoda Muhamdiramlage Indika Gunawardana
ASahmed shiyam
ahmed shiyam
MAMahendra Arnold
Mahendra Arnold

5 September 2025 in Research Square
Verified
Preprint
Open access
PDF file
WAW.D.J.K Amarasena
W.D.J.K Amarasena
SGSampatha Goonewardena
Sampatha Goonewardena
KWK D B M Wijeratne
K D B M Wijeratne
VSVajirapani De Silva
Vajirapani De Silva
DGDeepa Gangoda Gamage
Deepa Gangoda Gamage
Introduction The Human Papilloma Virus (HPV) infection is known to cause anogenital cancers. Male HPV prevalence and population-attributable risk (PAR)are important to plan future HPV preventive strategies for HPV-driven anogenital cancers in males. Methods A hospital-based case-control study was carried out to determine the etiologic fraction attributed to HPV-driven anal and penile(anogenital) cancers among male patients presenting to tertiary care hospitals in Gampaha district and Apeksha Hospital (cancer specialized), Sri Lanka and to calculate PAR percentage on anogenital SCC among the study population where HPV prevalence was 5.7%. New or already diagnosed patients for anal and penile SCC who reported to selected hospitals from August 2022 to June 2023 were recruited for data and specimen collection. A sample size of 20 cases and 80 controls were selected, with four controls chosen per case from sexually active, clinically normal men aged 20-70 years residing in the Gampaha district. Additional etiological factors that were checked included the presence of sexually transmitted infections, phimosis, anogenital injury, and the use of tobacco, alcohol or illegal drugs. The chi-square test was used at the level p<0.05 significance. Bivariable and logistic regression analyses were used to calculate odds ratios (ORs). Results A significantly associated factor for getting anal and penile SCC was HPV infection (p<0.001; adjusted OR: 27.7; 95% CI: 4.3,177.8).For any HPV genotype & high-risk HPV genotype, prevalence was 55% & 50% among cases and 5% & 2.5% among controls respectively. Assuming prevalence among controls as the population prevalence, the calculated PAR% was 62.2% for any HPV genotype and 33% for the HPV 16 HR genotype. Conclusions Sixty-two per cent of the anal and penile SCCs were attributed to any HPV genotype and one-third of anal and penile SCCs can be prevented by introducing HPV 16 genotype-containing vaccine to male.

23 April 2026 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
WAW.D.J.K Amarasena
W.D.J.K Amarasena
SGSampatha Goonewardena
Sampatha Goonewardena
DGDeepa Gangoda Gamage
Deepa Gangoda Gamage
Human Papillomavirus (HPV) infection is the most common sexually transmitted viral infection in the world. Persistent infection lasting more than two years

27 December 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
WAW.D.J.K Amarasena
W.D.J.K Amarasena
SGSampatha Goonewardena
Sampatha Goonewardena
KWK. D. B. M. Wijeratne
K. D. B. M. Wijeratne
VSVajirapani De Silva
Vajirapani De Silva
DGDeepa Gangoda Gamage
Deepa Gangoda Gamage
The Human Papillomavirus (HPV) infection is known to cause anogenital cancers. Male HPV prevalence and Population Attributable Risk (PAR) are important to